BlackRock, Inc. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 11,210,671 6.700% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 11,210,671 6.700% | 3,049,924 (+37.37%) | Filing |
| 2024-02-07 5:09 pm Sale | 2024-01-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 8,160,747 4.900% | -256,777 (-3.05%) | Filing |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 8,417,524 5.000% | 7,343,033 (+683.40%) | Filing |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 1,074,491 4.500% | 40,988 (+3.97%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 1,033,503 6.300% | 1,033,503 (New Position) | Filing |